Agena Bioscience Granted EUA for High-Throughput, Low-Cost SARS-CoV-2 Panel
The Pharma Data
OCTOBER 27, 2020
Food and Drug Administration (FDA). Agena Bioscience develops, manufactures, and supplies genetic analysis systems and reagents, including the MassARRAY ® System. SAN DIEGO , Oct. “To address the crisis presented by COVID-19, labs need to cost-effectively process large numbers of samples.
52 
Let's personalize your content